Clinical trials
Multiple Myeloma trials in South Africa
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 2 |
| GlaxoSmithKline | 2 |
| National Cancer Institute (NCI) | 2 |
| Takeda | 2 |
| AbbVie | 1 |
| Gary Morrow | 1 |
| Janssen Pharmaceutica N.V., Belgium | 1 |
| Janssen Research & Development, LLC | 1 |
| Millennium Pharmaceuticals, Inc. | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 15 |
| Neoplasms, Plasma Cell | 3 |
| Recurrence | 3 |
| Blood Protein Disorders | 1 |
| Hematologic Diseases | 1 |
| Infections | 1 |
| Leukemia, Plasma Cell | 1 |
| Lymphoma, B-Cell | 1 |
| Lymphoma, Large B-Cell, Diffuse | 1 |
| Lymphoma, Mantle-Cell | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.